Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Create an account to see the full posting, access our search engine, and more.You're just 60 seconds away from your new Creativeloft account.